Planet 13 Holdings (PLNH) Restructuring Costs (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Restructuring Costs of $2.2 million for Q1 2026, down 17.97% year-over-year from $2.7 million in Q1 2025, and up 16.24% quarter-over-quarter from $1.9 million in Q4 2025.
Planet 13 Holdings (PLNH) Restructuring Costs (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Restructuring Costs for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs fell 17.97% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $8.6 million (down 1.97% YoY), while the FY2025 annual figure was $9.1 million, up 18.21% from the prior year.
- Restructuring Costs advanced to $2.2 million in Q1 2026 per PLNH's latest filing, from $1.9 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $2.7 million in Q1 2025 and bottomed at $639164.0 in Q1 2022.
- Historically, Restructuring Costs has averaged $1.7 million across 5 years, with a median of $1.7 million in 2022.
- On a YoY basis, Restructuring Costs climbed as much as 124.03% in 2022 and fell as far as 24.58% in 2022.
- Planet 13 Holdings' Restructuring Costs stood at $916351.0 in 2022, then soared by 37.44% to $1.3 million in 2023, then soared by 45.06% to $1.8 million in 2024, then advanced by 2.75% to $1.9 million in 2025, then rose by 16.24% to $2.2 million in 2026.
- Business Quant data shows PLNH's Restructuring Costs at $2.2 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 916,351.00 |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 639,164.00 |
| Dec 31, 2021 | -3.81 Mn |
| Sep 30, 2021 | 2.21 Mn |